Internal Medicine, Rheumatology · Albany, NY
NPI
1891956751
Since 2008
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4 Tower Pl, 8th Floor
Albany, NY, 12203
Phone (518) 489-4471
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
87,017 services
Medicare patients, 2024
487
Average age 73
Drug cost, 2024
$6.2M
3,680 prescriptions
Company payments, 2025
$1,534
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aixa E Toledo-Garcia was code J0897 (injection, denosumab, 1 mg), 4,020 times for 41 patients. In total Aixa E Toledo-Garcia billed 87,017 services in 53 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 4,020 | 41 | $19.97 | $80K |
| J9312 Injection, rituximab, 10 mg | Office | 3,653 | 13 | $56.97 | $208K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 3,290 | 11 | $24.77 | $81K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,000 | 17 | $0.23 | $225 |
| 99214 Office E&M - Established | Office | 913 | 465 | $89.51 | $82K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 739 | 414 | $12.36 | $9,136 |
| 36415 Venipuncture Blood Collection | Office | 427 | 201 | $8.63 | $3,685 |
| 85025 Blood Count | Office | 366 | 185 | $7.55 | $2,764 |
| 85651 Clinical Chemistry | Office | 330 | 162 | $4.14 | $1,368 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 324 | 62 | $0.51 | $165 |
| 96413 Chemotherapy Administration | Office | 307 | 45 | $99.47 | $31K |
| 96415 Chemotherapy Administration | Office | 164 | 24 | $20.94 | $3,435 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 100 | 20 | $4.26 | $426 |
| 96401 Chemotherapy Administration | Office | 83 | 40 | $55.38 | $4,597 |
| 73130 X-ray - Upper Extremity | Office | 54 | 28 | $28.11 | $1,518 |
By year: 2022 $952K for 73,239 services; 2023 $1.1M for 76,599 services; 2024 $1.2M for 87,017 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 427 | 201 | $8.63 | $3,685 |
| 85025 Blood Count | 366 | 185 | $7.55 | $2,764 |
| 85651 Clinical Chemistry | 330 | 162 | $4.14 | $1,368 |
Medicare prescription drug claims, 2024
In 2024, the drug Aixa E Toledo-Garcia prescribed most often to Medicare patients was Prednisone, with 600 prescriptions and refills. In total Aixa E Toledo-Garcia wrote 3,680 Medicare prescriptions that cost $6.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 600 | 1,403 | 179 | $6,970 |
| Hydroxychloroquine Sulfate Generic | 508 | 1,367 | 154 | $18K |
| Methotrexate Methotrexate Sodium | 503 | 1,296 | 149 | $17K |
| Enbrel Sureclick Etanercept | 140 | 191 | 26 | $1.4M |
| Celecoxib Generic | 121 | 302 | 38 | $3,896 |
| Sulfasalazine Generic | 113 | 275 | 29 | $3,683 |
| Allopurinol Generic | 108 | 306 | 29 | $1,087 |
| Methylprednisolone Generic | 95 | 111 | 65 | $1,216 |
| Leflunomide Generic | 87 | 226 | 24 | $9,841 |
| Meloxicam Generic | 86 | 223 | 30 | $572 |
| Tramadol Hcl Generic | 77 | 79 | 23 | $448 |
| Xeljanz Xr Tofacitinib Citrate | 66 | 90 | 11 | $481K |
| Mycophenolate Mofetil Generic | 62 | 138 | 16 | $5,716 |
| Humira Pen Adalimumab | 54 | 78 | Under 11 | $776K |
| Sulfasalazine Dr Sulfasalazine | 49 | 125 | 13 | $3,028 |
Brand drugs: - claims; generic drugs: 2,877 claims; opioid claims: 171.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aixa E Toledo-Garcia $1,534 ($1,534 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $659.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 35 | $659 |
| Amgen Inc. AMGN | 16 | $274 |
| Janssen Biotech, Inc. JNJ | 4 | $146 |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $136 |
| Pfizer Inc. PFE | 4 | $92.9 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $62.61 |
| GlaxoSmithKline, LLC. GSK | 2 | $52.83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $33.64 |
| Aurinia Pharma U.S., Inc. AUPH | 1 | $27.17 |
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $25.48 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.